Quantitative determinants of the outcome of asymptomatic mitral regurgitation
- PMID: 15745978
- DOI: 10.1056/NEJMoa041451
Quantitative determinants of the outcome of asymptomatic mitral regurgitation
Abstract
Background: The clinical outcome of asymptomatic mitral regurgitation is poorly defined, and the treatment is uncertain. We studied the effect on the outcome of quantifying mitral regurgitation according to recent guidelines.
Methods: We prospectively enrolled 456 patients (mean [+/-SD] age, 63+/-14 years; 63 percent men; ejection fraction, 70+/-8 percent) with asymptomatic organic mitral regurgitation, quantified according to current recommendations (regurgitant volume, 66+/-40 ml per beat; effective regurgitant orifice, 40+/-27 mm2).
Results: The estimated five-year rates (+/-SE) of death from any cause, death from cardiac causes, and cardiac events (death from cardiac causes, heart failure, or new atrial fibrillation) with medical management were 22+/-3 percent, 14+/-3 percent, and 33+/-3 percent, respectively. Independent determinants of survival were increasing age, the presence of diabetes, and increasing effective regurgitant orifice (adjusted risk ratio per 10-mm2 increment, 1.18; 95 percent confidence interval, 1.06 to 1.30; P<0.01), the predictive power of which superseded all other qualitative and quantitative measures of regurgitation. Patients with an effective regurgitant orifice of at least 40 mm2 had a five-year survival rate that was lower than expected on the basis of U.S. Census data (58+/-9 percent vs. 78 percent, P=0.03). As compared with patients with a regurgitant orifice of less than 20 mm2, those with an orifice of at least 40 mm2 had an increased risk of death from any cause (adjusted risk ratio, 2.90; 95 percent confidence interval, 1.33 to 6.32; P<0.01), death from cardiac causes (adjusted risk ratio, 5.21; 95 percent confidence interval, 1.98 to 14.40; P<0.01), and cardiac events (adjusted risk ratio, 5.66; 95 percent confidence interval, 3.07 to 10.56; P<0.01). Cardiac surgery was ultimately performed in 232 patients and was independently associated with improved survival (adjusted risk ratio, 0.28; 95 percent confidence interval, 0.14 to 0.55; P<0.01).
Conclusions: Quantitative grading of mitral regurgitation is a powerful predictor of the clinical outcome of asymptomatic mitral regurgitation. Patients with an effective regurgitant orifice of at least 40 mm2 should promptly be considered for cardiac surgery.
Copyright 2005 Massachusetts Medical Society.
Comment in
-
Timing of surgery in asymptomatic mitral regurgitation.N Engl J Med. 2005 Mar 3;352(9):928-9. doi: 10.1056/NEJMe048334. N Engl J Med. 2005. PMID: 15745985 No abstract available.
-
Surgery for asymptomatic mitral regurgitation.N Engl J Med. 2005 May 26;352(21):2245-6; author reply 2245-6. doi: 10.1056/NEJM200505263522119. N Engl J Med. 2005. PMID: 15917393 No abstract available.
Similar articles
-
Quantitative echocardiographic determinants of clinical outcome in asymptomatic patients with aortic regurgitation: a prospective study.JACC Cardiovasc Imaging. 2008 Jan;1(1):1-11. doi: 10.1016/j.jcmg.2007.10.008. JACC Cardiovasc Imaging. 2008. PMID: 19356398
-
Outcomes in mitral regurgitation due to flail leaflets a multicenter European study.JACC Cardiovasc Imaging. 2008 Mar;1(2):133-41. doi: 10.1016/j.jcmg.2007.12.005. JACC Cardiovasc Imaging. 2008. PMID: 19356418
-
Comprehensive Imaging in Women With Organic Mitral Regurgitation: Implications for Clinical Outcome.JACC Cardiovasc Imaging. 2016 Apr;9(4):388-96. doi: 10.1016/j.jcmg.2016.02.017. JACC Cardiovasc Imaging. 2016. PMID: 27056158
-
[The best of valvular heart disease in 2006].Arch Mal Coeur Vaiss. 2007 Jan;100 Spec No 1:19-28. Arch Mal Coeur Vaiss. 2007. PMID: 17405561 Review. French.
-
[Calculation of the regurgitation fraction in mitral insufficiency by Doppler echocardiography using a study of the zone of flow convergence].Arch Mal Coeur Vaiss. 1997 Jan;90(1):17-25. Arch Mal Coeur Vaiss. 1997. PMID: 9137711 Review. French.
Cited by
-
Recommendation of Early Surgery in Primary Mitral Regurgitation: Pros and Cons.Arq Bras Cardiol. 2016 Aug;107(2):173-5. doi: 10.5935/abc.20160107. Arq Bras Cardiol. 2016. PMID: 27627641 Free PMC article. Review. No abstract available.
-
Area strain from 3D speckle-tracking echocardiography as an independent predictor of early symptoms or ventricular dysfunction in asymptomatic severe mitral regurgitation with preserved ejection fraction.Int J Cardiovasc Imaging. 2016 Aug;32(8):1189-98. doi: 10.1007/s10554-016-0904-2. Epub 2016 May 9. Int J Cardiovasc Imaging. 2016. PMID: 27161336
-
Subclinical left ventricular systolic dysfunction in chronic mitral regurgitation and its potential impact on management: quo vadis?Indian Heart J. 2012 May-Jun;64(3):249-53. doi: 10.1016/S0019-4832(12)60081-9. Indian Heart J. 2012. PMID: 22664805 Free PMC article. No abstract available.
-
Sutureless Aortic Prosthesis Valves versus Transcatheter Aortic Valve Implantation in Intermediate Risk Patients with Severe Aortic Stenosis: A Literature Review.J Clin Med. 2024 Sep 20;13(18):5592. doi: 10.3390/jcm13185592. J Clin Med. 2024. PMID: 39337078 Free PMC article. Review.
-
Early predictors of cardiac decompensation in experimental volume overload.Mol Cell Biochem. 2010 May;338(1-2):271-82. doi: 10.1007/s11010-009-0361-5. Epub 2010 Jan 7. Mol Cell Biochem. 2010. PMID: 20054615
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials